Functional enrichment analyses further suggested that EIF2B4 may drive HCC progression via dual mechanisms: directly accelerating tumor cell cycle progression through translation reprogramming, and shaping an immunosuppressive microenvironment via aberrant synthesis of immune-modulatory molecules. This evidence concerns the gene EIF2B4 and hepatocellular carcinoma.